PROVIDER PROFILE · NPI 1639180300
Vinay GowdaMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
557
Unique beneficiaries
—
Total services
8,292
Distinct HCPCS
13
Medicare payment
$76K
Peer benchmark
Total Medicare services vs. 329 Allergy/ Immunology providers in CA — top quintile (cohort median 4,377).
PRESCRIBING · PART D · 2024
Total Rx claims
615
Beneficiaries
—
Total drug cost
$192K
Distinct drugs
19
Brand share
41.3%
Top prescribed drugs
Montelukast Sodium121 claims
Azelastine Hcl84 claims
Albuterol Sulfate41 claims
Fluticasone Propionate40 claims
Fluticasone/Vilanterol30 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$1K
Payment records
10
By payment type
Food and Beverage$1K
Top paying entities
Food and Beverage$1K
REFERRAL NETWORK
Where Vinay Gowda's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Jon Keller Pathology · Palo Alto, CA | 67 | 224 |
| Daniel Kim Allergy/ Immunology · Santa Cruz, CA | 59 | 355 |
| DIGNITY HEALTH | 11 | 16 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE